Recent newsletters
December 2022 Newsletter
- Right2Survive Advocacy recap
- Our 2022 Webinar Series Wraps Up
- Friends Remembered: Jill Hamer-Wilson
- We Have New Resources on our Website for Liver Cancer
- CCSN calls for a pan-Canadian health data strategy
- The other lung cancer risk that is not often discussed
- Thank you for your support on Giving Tuesday
October 2022 newsletter
- CCSN publishes For Cancer Patients and Caregivers, the Pandemic is Not Over
- Cancer Can’t Wait: CCSN Virtual Advocacy Weeks Continue
- A Review of Precision Medicine Companion Diagnostics in Canada: Are we there yet?
- The CCSN Webinar Series is back!
- CCSN has a new partner
[/GDC_column]
September 2022 newsletter
- The Pandemic is Still Taking a Toll on Caregivers
- Impact of Earlier Routine Mammograms
- Become a patient advocate with CCSN!
- Prostate Cancer Advisory Council
- Survey on Lumakras for Lung Cancer Patients and Caregivers
- Coming Soon! Cancer Survivor to Financial Survivor
August 2022 newsletter
July 2022 newsletter
Highlights from this issue:
- Free CCSN Webinar – July 13: Why Cancer Still Sucks, and So Does Access to Treatment in Canada, with David Stewart, MD. Register here!
- Council of the 21,247 – July 11 Twitter Event
- Cancer Conferences
- New Website for the International Liver Cancer Movement
- CCSN’s newsletter is now available in French! Abonnez-vous ici!
June 2022 newsletter
Highlights from this issue:
- The release of the report on CCSN’s first three surveys on COVID-19 and Cancer, titled “Thrown Under the Bus: Disruption of Cancer Care in Canada During the COVID-19 Pandemic”
- Coming soon: CCSN’s fourth survey, following up on the first three to find out how cancer patients and caregivers are doing as public health restrictions lift, two years into the pandemic.
- Register for our webinar on June 23 to find out about the results of the fourth survey!
[/GDC_row]
May 2022 newsletter
Highlights from this issue:
- CCSN asks Ontario election candidates and parties how they will deal with pressing issues affecting cancer patients and survivors
- Patient organizations commend the government’s announcement regarding amendments to Canada’s drug pricing regulations
- Register now for CCSN’s next webinar on May 12 on the topic of “Engaging Patients and Caregivers with Clinical Trials”
- CCSN’s surveys for cancer patients taking Keytruda for cervical cancer or Darolutamide for prostate cancer
April 2022 Newsletter
